期刊文献+

融合蛋白GST-hS100A2对人结肠癌细胞HCT116和SW480的抑制作用 被引量:1

Inhibitory Effect of GST-hS100A2 Fusion Protein on Human Colorectal Carcinoma HCT116 and SW480 Cells
原文传递
导出
摘要 目的探讨GST-人S100A2融合蛋白(GST-hS100A2)对人结肠癌细胞HCT116和SW480的抑制作用。方法将重组质粒pGST-moluc-hS100A2和pGST-moluc转化大肠杆菌BL21(DE3),IPTG诱导表达,Western blot鉴定后采用谷胱甘肽-琼脂糖4B球珠分离纯化。以制备的GST-hS100A2融合蛋白分别处理HCT116和SW480细胞,以GST处理的细胞和空白细胞作为对照,分别用MTT法检测细胞增殖活力,Hochest33258染色检测细胞凋亡,流式细胞术检测细胞周期,划痕愈合法检测细胞迁移能力,Transwell小室试验检测细胞侵袭能力。结果融合蛋白GST-hS100A2能以剂量依赖和时间依赖的方式抑制HCT116和SW480细胞的增殖,并可明显促进两种细胞凋亡,阻滞HCT116细胞周期,抑制HCT116细胞迁移和两种细胞的侵袭能力。结论 GST-hS100A2对人结肠癌HCT116和SW480细胞具有一定的抑制作用,有可能成为结肠癌分子治疗的新靶标。 Objective To investigate the inhibitory effect of fusion protein GST-hS100A2 on human colorectal carcinoma HCT-116 and SW480 cells.Methods Recombinant plasmids pGST-moluc-hS100A2 and pGST-moluc were transformed to E.coli BL21(DE3) for expression under induction of IPTG.The expressed products were identified by Western blot,then purified with Glutathion-Sepharose 4B beads.HCT116 and SW480 cells were treated with the prepared GST-hS100A2 fusion protein,using those treated with GST and those untreated as controls,and determined for proliferative activity by MTT method,for apoptosis by Hochest33258 staining,for cell cycle by flow cytometry,for migration ability by wound healing assay,and for invasion ability by Transwell test.Results GST-hS100A2 showed dose-and time-dependent inhibitory effect on the proliferation of HCT116 and SW480 cells.Meanwhile,the fusion protein significantly promoted the apoptosis and inhibited the invasion ability of both HCT116 and SW480 cells,while arrested the cell cycle and inhibited the migration of HCT116 cells.Conclusion GST-hS100A2 showed a certain inhibitory effect on HCT116 and SW480 cells and might be used as a new target for molecular therapy of colorectal carcinoma.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第7期775-781,共7页 Chinese Journal of Biologicals
基金 国家自然科学基金(30772548)
关键词 人S100A2 融合蛋白 结肠肿瘤 抑制 Human S100A2; Fusion protein; Colorectal tumor; Inhibition
  • 相关文献

参考文献2

二级参考文献29

  • 1Gupta S,Hussain T,MacLennan G T,et al. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma[J]. J Clin Oncol, 2003,21 ( 1 ) : 106-112.
  • 2Matsubara D,Niki T,Ishikawa S,et al. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathotogical significance,relationship to p53 and identification of their target genes[J]. Cancer Sci, 2005,96( 12 ) : 844-857.
  • 3Zhang X,Hunt J L,Shin D M,et al. Down-regulation of S100A2 in lymph node metastases of head and neck cancer[J]. Head Neck, 2007,29(3 ) : 236-243.
  • 4Ok-Jae L,Seung-Mo H,Mohammad H R,et al. Expression of calcium-binding proteins S100A2 and S100A4 in barrett's adenocarcinomas[J]. Neoplasia, 2006,8 (10) : 843-850.
  • 5Imazawa M,Hibi K,Fujitake S,et ah S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma[J]. Anticancer Res,2005,25 (2B) : 1247-1250.
  • 6Park H R,Min S K. Expression of S100A2 and S100B proteins in epithelial tumors of the skin[J]. J Cutan Patho,2003,30(6):373-378.
  • 7Engelkamp D,Schafer BW,Mattei MG,Erne P,Heizmann CW.Six S100 genes are clustered on human chromosome 1q21:identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E.Proc Natl Acad Sci USA 1993;90:6547-6551.
  • 8Nakayama S,Kretsinger RH.Evolution of the EF-hand family of proteins.Annu Rev Biophys Biomol Struct 1994;23:473-507.
  • 9Wicki R,Franz C,Scholl FA,Heizmann CW,Schafer BW.Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation.Cell Calcium 1997;22:243-254.
  • 10Yang A,Kaghad M,Wang Y,Gillett E,Fleming MD,Dotsch V,Andrews NC,Caput D,McKeon F.p63,a p53 homolog at 3q27-29,encodes multiple products with transactivating,death-inducing,and dominant-negative activities.Mol Cell 1998;2:305-316.

共引文献6

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部